AAAAAA

   
Results: 1-10 |
Results: 10
An economic overview of chronic obstructive pulmonary disease
Authors: Ruchlin, HS Dasbach, EJ
Citation: Hs. Ruchlin et Ej. Dasbach, An economic overview of chronic obstructive pulmonary disease, PHARMACOECO, 19(6), 2001, pp. 623-642
The multinational impact of migraine symptoms on healthcare utilisation and work loss
Authors: Gerth, WC Carides, GW Dasbach, EJ Visser, WH Santanello, NC
Citation: Wc. Gerth et al., The multinational impact of migraine symptoms on healthcare utilisation and work loss, PHARMACOECO, 19(2), 2001, pp. 197-206
Mortality and costs of acute renal failure associated with amphotericin B therapy
Authors: Bates, DW Su, L Yu, DT Chertow, GM Seger, DL Gomes, DRJ Dasbach, EJ Platt, R
Citation: Dw. Bates et al., Mortality and costs of acute renal failure associated with amphotericin B therapy, CLIN INF D, 32(5), 2001, pp. 686-693
Burden of aspergillosis-related hospitalizations in the United States (vol31, pg 1524, 2000)
Authors: Dasbach, EJ Davies, GM Teutsch, SM
Citation: Ej. Dasbach et al., Burden of aspergillosis-related hospitalizations in the United States (vol31, pg 1524, 2000), CLIN INF D, 32(4), 2001, pp. 673-673
The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial
Authors: Chrischilles, EA Dasbach, EJ Rubenstein, LM Cook, JR Tabor, HK Black, DM
Citation: Ea. Chrischilles et al., The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial, OSTEOPOR IN, 12(8), 2001, pp. 654-660
Analysis of health economic data
Authors: Cook, JR Carides, GW Dasbach, EJ
Citation: Jr. Cook et al., Analysis of health economic data, APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY: WITH CASE STUDIES USINGS-PLUS, 2001, pp. 427-454
Burden of aspergillosis-related hospitalizations in the United States
Authors: Dasbach, EJ Davies, GM Teutsch, SM
Citation: Ej. Dasbach et al., Burden of aspergillosis-related hospitalizations in the United States, CLIN INF D, 31(6), 2000, pp. 1524-1528
Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy
Authors: Cowley, AJ Wiens, BL Segal, R Rich, MW Santanello, NC Dasbach, EJ Pitt, B
Citation: Aj. Cowley et al., Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy, QUAL LIFE R, 9(4), 2000, pp. 377-384
Work and productivity loss in the rizatriptan multiple attack study
Authors: Dasbach, EJ Carides, GW Gerth, WC Santanello, NC Pigeon, JG Kramer, MS
Citation: Ej. Dasbach et al., Work and productivity loss in the rizatriptan multiple attack study, CEPHALALGIA, 20(9), 2000, pp. 830-834
The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure
Authors: Dasbach, EJ Rich, MW Segal, R Gerth, WC Carides, GW Cook, JR Murray, JF Snavely, DB Pitt, B
Citation: Ej. Dasbach et al., The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure, CARDIOLOGY, 91(3), 1999, pp. 189-194
Risultati: 1-10 |